CASI Pharmaceuticals Inc — Cash Flow (NASDAQ:CASI) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities 21.09 M19.97 M29.2 M — Cash from investing activities 31.16 M9.67 M11.24 M — Cash from financing activities 3.27 M907 K15.43 M — Free cash flow 15.48 M17.73 M28.96 M —

뉴스

What Drove CASI Pharmaceuticals' 24% Rise After Hours? - CASI Pharmaceuticals (NASDAQ:CASI)

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.63%

CASI 제약, 나스닥 상장 폐지 통보에 주가 급락

CASI Pharmaceuticals stock plunges on Nasdaq delisting notice

Is Alkermes (ALKS) Outperforming Other Medical Stocks This Year?

Are Medical Stocks Lagging Alkermes (ALKS) This Year?

China approves CASI Pharmaceuticals’ CID-103 clinical trial for kidney rejection

CASI Pharmaceuticals, 나스닥 상장 연장 승인 후 주가 급등

카스, 나스닥 상장 유지 기한 2026년 2월까지 연장

CASI Pharmaceuticals stock surges after Nasdaq grants listing extension

Casi Pharmaceuticals secures Nasdaq listing extension until February 2026

CASI Pharmaceuticals secures $20 million funding for transplant rejection study